A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of DHA on Cognitive Functions in the Elderly

Trial Profile

A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of DHA on Cognitive Functions in the Elderly

Completed
Phase of Trial: Phase III

Latest Information Update: 13 Jun 2014

At a glance

  • Drugs Docosahexaenoic acid (Primary)
  • Indications Alzheimer's disease
  • Focus Therapeutic Use
  • Acronyms MIDAS
  • Sponsors Martek Biosciences Corporation
  • Most Recent Events

    • 04 Nov 2010 Results from this trial were published in the November issue of Alzheimer's & Dementia: The Journal of the Alzheimer's Association, according to a Martek Biosciences media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top